Fundraising Fox

OccuRx

3 known investors

Therapies for fibrotic and inflammatory diseases associated with diabetes complications

Investors · 3

Stoic VCSydney · $65K – $650K
Brandon BioCatalystreportedMelbourne
Brandon Capital Partnersreported

In the news

Certa Therapeutics Expands GPR68 Platform through Acquisition of OccuRxglobenewswire.com · Dec 2024Biotech startup OccuRx raises $16 million for kidney disease trial - Startup Dailystartupdaily.net · Sep 2022OccuRx secures funding to progress potential inflammation and fibrosis therapy - Biotechbiotechdispatch.com.au · Sep 2022

Frequently asked questions

What does OccuRx do?
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Who are OccuRx's investors?
OccuRx's investors include Stoic VC, Brandon BioCatalyst, Brandon Capital Partners.